Toward a world consensus on prevention of schizophrenia

Dialogues in Clinical Neuroscience

Volumn 7, Issue 1, 2005, Pages 53-67

  Van Os, Jim ^a,b   Delespaul, Philippe ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Prediction; Psychotic disorder; Sample enrichment strategy; Schizophrenia; Screening; Sensitivity; Specificity

Indexed keywords

COMORBIDITY; COPING BEHAVIOR; DIAGNOSTIC ACCURACY; DISEASE MODEL; EARLY DIAGNOSIS; HIGH RISK POPULATION; HUMAN; MEDICAL RESEARCH; MENTAL HEALTH CARE; MENTAL HEALTH SERVICE; PREDICTION; PRIMARY PREVENTION; PSYCHIATRIC DIAGNOSIS; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SCREENING TEST;

HUMANS; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOPHRENIA; WORLD HEALTH;

EID: 17444370520     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. McGorry PD, Yung AR, Phillips LJ. The "close-in" or ultra high-risk model: a safe and effective strategy for research and clinical intervention in prepsychotic mental disorder. Schizophr Bull. 2003;29:771-790.
2. Warner R. Early intervention in schizophrenia: a critique. Epidemiol Psichiatr Soc. 2002;11:248-255.
3. Cougnard A, Salmi LR, Verdoux H. A decade of debate on early intervention in psychosis: a systematic review of screening criteria. Schizophr Res. 2003;60:91-93.
4. Lencz T, Smith CW, Auther AM, Correll CU, Cornblatt BA. The assessment of "prodromal schizophrenia": unresolved issues and future directions. Schizophr Bull. 2003;29:717-728.
5. Malla AM, Norman RM. Treating psychosis: is there more to early intervention than intervening early? Can J Psychiatry. 2001;46:645-648.
6. McGlashan TH. Commentary: progress, issues, and implications of prodromal research: an inside view. Schizophr Bull. 2003;29:851-858.
7. Parnas J. From predisposition to psychosis: progression of symptoms in schizophrenia. Acta Psychiatr Scand Suppl. 1999;395:20-29.
8. Verdoux H. Have the times come for early intervention in psychosis? Acta Psychiatr Scand. 2001;103:321-322.
9. Offenkrantz WC, Aldrich CK. The early diagnosis of psychosis. Med Clin North Am. 1960;44:237-248.
10. Treuting TF. The early recognition of psychosis. Bull Tulane Univ Med Fac. 1953;13:33-36.
11. Hafner H, Riecher Rossler A, Maurer K, Fatkenheuer B, Loffler W. First onset and early symptomatology of schizophrenia. A chapter of epidemiological and neurobiological research into age and sex differences. Eur Arch Psychiatry Clin Neurosci. 1992;242:109-118.
12. Johannessen JO, Larsen TK, McGlashan T. Duration of untreated psychosis: an important target for intervention in schizophrenia? Nord J Psychiatry. 1999;53:275-283.
13. Larsen TK, McGlashan TH, Moe LC. First-episode schizophrenia: I. Early course parameters. Schizophr Bull. 1996;22:241-256.
14. Hafner H, Loffler W, Maurer K, Hambrecht M, an der Heiden W. Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatr Scand. 1999;100:105-118.
15. Hafner H, Nowotny B. Epidemiology of early-onset schizophrenia. Eur Arch Psychiatry Clin Neurosci. 1995;245:80-92.
16. Crow TJ, MacMillan JF, Johnson AL, Johnstone EC. A randomised controlled trial of prophylactic neuroleptic treatment. Br J Psychiatry. 1986;148:120-127.
17. Loebel AD, Lieberman JA, Alvir JM, Mayerhoff DI, Geisler SH, Szymanski SR. Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry. 1992;149:1183-1188.
18. Verdoux H, Bergey C, Assens F, et al. Prediction of duration of psychosis before first admission. Eur Psychiatry. 1998;13:346-352.
19. Verdoux H, Liraud F, Bergey C, Assens F, Abalan F, Van Os J. Is the association between duration of untreated psychosis and outcome confounded? A 2-year follow-up study of first-admitted patients. Schizophr Res. 2001;49:231-241.
20. Norman RM, Malla AK. Duration of untreated psychosis: a critical examination of the concept and its importance. Psychol Med. 2001;31:381-400.
21. Norman RM, Malla AK, Verdi MB, Hassall LD, Fazekas C. Understanding delay in treatment for first-episode psychosis. Psychol Med. 2004;4:255-266.
22. Jones P, Rodgers B, Murray R, Marmot M. Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet. 1994;344:1398-1402.
23. Isohanni M, Isohanni I, Koponen H, et al. Developmental precursors of psychosis. Curr Psychiatry Rep. 2004;6:168-175.
24. Reichenberg A, Rabinowitz J, Weiser M, Mark M, Kaplan Z, Davidson M. Premorbid functioning in a national population of male twins discordant for psychoses. Am J Psychiatry. 2000;157:1514-1516.
25. Jones PB, Van Os J. Commentary: Behavioural and intellectual functioning in Israeli adolescent boys predicted psychiatric hospital admission for schizophrenia. Evidence-Based Ment Health. 2000;3:89.
26. Hafner H, Riecher-Rossler A, Hambrecht M, et al. IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophr Res. 1992;6:209-223.
27. Hafner H, Maurer K, Loffler W, Riecher-Rossler A. The influence of age and sex on the onset and early course of schizophrenia. Br J Psychiatry. 1993;162:80-86.
28. Carr V, Halpin S, Lau N, O'Brien S, Beckmann J, Lewin T. A risk factor screening and assessment protocol for schizophrenia and related psychosis. Aust N Z J Psychiatry. 2000;34(suppl):S170-S180.
29. Chapman LJ, Chapman JP, Kwapil TR, Eckblad M, Zinser MC. Putatively psychosis-prone subjects 10 years later. J Abnorm Psychol. 1994;103:171-183.
30. Chapman LJ, Edell WS, Chapman JP. Physical anhedonia, perceptual aberration, and psychosis proneness. Schizophr Bull. 1980;6:639-653.
31. Jenner JA, Van De Willige G. HIT, hallucination focused integrative treatment as early intervention in psychotic adolescents with auditory hallucinations: a pilot study. Acta Psychiatr Scand. 2001;103:148-152.
32. Kwapil TR, Miller MB, Zinser MC, Chapman J, Chapman LJ. Magical ideation and social anhedonia as predictors of psychosis proneness: a partial replication. J Abnorm Psychol. 1997;106:491-495.
33. McGorry PD. The nature of schizophrenia: signposts to prevention. Aust N Z J Psychiatry. 2000;34(suppl):S14-S21.
34. Phillips LJ, Yung AR, McGorry PD. Identification of young people at risk of psychosis: validation of Personal Assessment and Crisis Evaluation Clinic intake criteria. Aust N Z J Psychiatry. 2000;34(suppl):S164-S169.
35. Poulton R, Caspi A, Moffitt TE, Cannon M, Murray R, Harrington H. Children's self-reported psychotic symptoms and adult schizophreniform disorder, a 15-year longitudinal study. Arch Gen Psychiatry. 2000;57:1053-1058.
36. Eaton WW, Romanoski A, Anthony JC, Nestadt G. Screening for psychosis in the general population with a self-report interview. J Nerv Ment Dis. 1991;179:689-693.
37. Kendler KS, Gallagher TJ, Abelson JM, Kessler RC. Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey. Arch Gen Psychiatry. 1996;53:1022-1031.
38. Spauwen J, Krabbendam L, Lieb R, Wittchen HU, Van Os J. Sex differences in psychosis: normal or pathological? Schizophr Res. 2003;62:45-49.
39. Van Os J, Hanssen M, Bijl RV, Ravelli A. Straus (1969) revisited: a psychosis continuum in the general population? Schizophr Res. 2000;45:11-20.
40. Verdoux H, Maurice-Tison S, Gay B, Van Os J, Salamon R, Bourgeois ML. A survey of delusional ideation in primary-care patients. Psychol Med. 1998;28:127-134.
41. Tien AY, Eaton WW. Psychopathologic precursors and sociodemographic risk factors for the schizophrenia syndrome. Arch Gen Psychiatry. 1992;49:37-46.
42. Hanssen M, Bak M, Bijl R, Vollebergh W, Van Os J. The incidence and outcome of subclinical psychotic experiences in the general population. Br J Clin Psychol. 2004. In press.
43. Johns LC, Van Os J. The continuity of psychotic experiences in the general population. Clin Psychol Rev. 2001;21:1125-1141.
44. Van Os, J, Hanssen M, Bijl RV, Vollebergh W. Prevalence of psychotic disorder and community level of psychotic symptoms: an urban-rural comparison. Arch Gen Psychiatry. 2001;58:663-668.
45. Miller TJ, McGlashan TH, Rosen JL, et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry. 2002;159:863-865.
46. Yung AR, Phillips LJ, Yuen HP, et al. Psychosis prediction: 12-month follow-up of a high-risk ("prodromal") group. Schizophr Res. 2003;60:21-32.
47. Hanssen MS, Bijl RV, Vollebergh W, Van Os J. Self-reported psychotic experiences in the general population: a valid screening tool for DSM-III-R psychotic disorders? Acta Psychiatr Scand. 2003;107:369-377.
48. Maric N, Myin-Germeys I, Delespaul P, De Graaf R, Vollebergh W, Van Os J. Is our concept of schizophrenia influenced by Berkson's bias? Social Psychiatry Psychiatr Epidemiol. 2004;39:600-605.
49. Sackett DL, Richardson WS, Rosenberg W, Haynes RB. Evidence-Based Medicine. New York, NY: Churchill Livingstone; 1997.
50. Hennekens CH, Buring JE. Screening. In: Hennekens CH, Buring JE, eds. Epidemiology in Medicine. Toronto, Canada: Little, Brown and Company; 1987.
51. Bentall RP, Morrison AP. More harm than good: the case against using antipsychotic drugs to prevent severe mental illness. J Ment Health. 2002;11:351-356.
52. McGuire PK. Prodromal intervention: the need for evaluation. A reply to Bentall and Morrison. J Ment Health. 2002;114:469-470.
53. Warner R. Fact versus fantasy: a reply to Bentall and Morrison. J Ment Health. 2003;12:351-357.
54. Marshall M, Lockwood A. Early intervention for psychosis. Cochrane Database Syst Rev. 2004:CD004718.
55. Bak M, Myin-Germeys I, Hanssen M, et al. When does experience of psychosis result in a need for care? A prospective general population study. Schizophr Bull. 2003;29:349-358.
56. Garety PA, Kuipers E, Fowler D, Freeman D, Bebbington PE. A cognitive model of the positive symptoms of psychosis. Psychol Med. 2001;31:189-195.
57. Krabbendam L, Janssen I, Bak M, Bijl RV, de Graff R, Van Os J. Neuroticism and low self-esteem as risk factors for psychosis. Social Psychiatry Psychiatr Epidemiol. 2002;37:1-6.
58. Krabbendam L, Myin-Germeys I, Hanssen M, De Graaf R, Vollebergh W, Bak M, Van Os J. Development of depressed mood predicts onset of psychotic disorder in individuals who report hallucinatory experiences. Br J Clin Psychol. 2004. In press.
59. Wittchen HU. Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res. 1994;28:57-84.
60. Van Os J, Bak M, Hanssen M, Bijl RV, de Graaf R, Verdoux H. Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol. 2002;156:319-327.
61. Van Os J, Hanssen M, Bak M, Bijl RV, Vollebergh W. Do urbanicity and familial liability coparticipate in causing psychosis? Am J Psychiatry. 2003;160:477-482.
62. Davidson M, Reichenberg A, Rabinowitz J, Weiser M, Kaplan Z, Mark M. Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am J Psychiatry. 1999;56:1328-1335.
63. Klosterkotter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry. 2001;58:158-164.
64. Huber G. [Prodromal symptoms in schizophrenia]. Fortsch Neurol Psychiatr. 1995;63:131-138.
65. StataCorp STATA Statistical Software: Release 8.0. Texas: College Station; 2002.
66. Van Os J, Takei N, Verdoux H, Delespaul P. Early detection of schizophrenia [letter]. Br J Psychiatry. 1997;170:579.
67. Kuipers E, Holloway F, Rabe-Hesketh S, Tennakoon L. An RCT of early intervention in psychosis: Croydon Outreach and Assertive Support Team (COAST). Soc Psychiatry Psychiatr Epidemiol. 2004;39:358-363.
68. Rose G. The Strategy of Prevention. Oxford, UK: Oxford Medical Publications; 1992.
69. Goldberg D, Huxley P. Mental Illness in the Community. London, UK: Tavistock Publications; 1980.
70. Johannessen JO. Early intervention and prevention in schizophrenia- experiences from a study in Stavanger, Norway. Seishin Shinkeigaku Zasshi Psychiatr Neurol Jpn. 1998;100:511-522.
71. Johannessen JO, McGlashan TH, Larsen TK, et al. Early detection strategies for untreated first-episode psychosis. Schizophr Res. 2001;51:39-46.
72. Carbone S, Harrigan S, McGorry PD, Curry C, Elkins K. Duration of untreated psychosis and 12-month outcome in first-episode psychosis: the impact of treatment approach [see comments]. Acta Psychiatr Scand. 1999;100:96-104.
73. Malla A, Norman R, McLean T, Scholten D, Townsend L. A Canadian programme for early intervention in non-affective psychotic disorders. Aust N Z J Psychiatry. 2003;37:407-413.
74. Bak M, Delespaul P, Hanssen M, de Graaf R, Vollebergh W, van Os J. How false are "false" positive psychotic symptoms? Schizophr Res. 2003;62:187-189.
75. Bak M, Radstake S, Van Os J. Consultatie aan huisartsen ter detectie van zorgvermijdende mensen met een psychose. Maandblad Geestelijke Volksgezondheid. 1999;54:1281-1289.
76. Jones PB, Tarrant CJ. Developmental precursors and biological markers for schizophrenia and affective disorders: specificity and public health implications. Eur Arch Psychiatry Clin Neurosci. 2000;250:286-291.
77. Hanssen M, Peeters F, Krabbendam L, Radstake S, Verdoux H, Van Os J. How psychotic are individuals with non-psychotic disorders? Social Psychiatry Psychiatr Epidemiol. 2003;38:149-154.
78. Van Os J, Verdoux H, Maurice-Tison S, et al. Self-reported psychosis-like symptoms and the continuum of psychosis. Social Psychiatry Psychiatr Epidemiol. 1999;34:459-463.